1. Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014;130:820–8.
2. Valderrama AL, Gillespie C, Mercado C. Racial/ethnic disparities in the awareness, treatment, and control of hypertension—United States, 2003–2010. MMWR Morb Mortal Wkly Rep. 2013;62(18):351–5. This governmental report provides recent detailed information on racial/ethnic disparities, especially on BP control according to the NHANES period of 2003–2010.
3. Ferdinand KC. Improving approaches to hypertension treatment in African Americans: lessons learned from the Jackson Heart Study. J Clin Hypert. 2013;15:362–4.
4. Website: Collection of Race and Ethnicity Data in Clinical Trials Guidance for Industry - Collection of Race and Ethnicity Data in Clinical Trials. Accessed: 9/9/14 http://www.fda.gov/RegulatoryInformation/Guidances/ucm126340.htm .
5. Davis SK, Gebreab S, Quarells R, Gibbons GH. Social determinants of cardiovascular health among black and white women residing in Stroke Belt and Buckle regions of the South. Ethn Dis. 2014;24(2):133–43. This paper discusses the social determinants of health, specifically among black versus white women, and the disproportionate effects on CVD.